⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

August 31, 2024Journal of Assisted Reproduction and GeneticsOpen Access

A multi-centre randomised controlled trial comparing megestrol acetate to levonorgestrel-intrauterine system in fertility sparing treatment of atypical endometrial hyperplasia

C. Goh M Loh Whui Whui Lim Joella Xiahong Ang Ravichandran Nadarajah Tze Tein Yong Pearl Tong Yen Yeo Jessie Wai Leng Phoon

View Full Paper

Ask AI

Bookmark

Share

Abstract

The objective of the trial was to compare the regression rate of atypical endometrial hyperplasia (AEH) in patients treated with megestrol acetate (MA) vs. levonorgestrel-intrauterine device (LNG-IUS). We also aimed to assess the fertility and pregnancy outcomes in these patients.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Goh et al. (2024) studied this question.

synapsesocial.com/papers/68e5a0adb6db64358753b8ef https://doi.org/10.1007/s10815-024-03172-z

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Pregnancy Outcomes Following Medical Therapy versus Levonorgestrel-Releasing Intrauterine System for Atypical Endometrial HyperplasiaCohort Study · 2026 · 1 citations
2Levonorgestrel intrauterine system as a management of abnormal uterine bleeding with endometrial hyperplasia without atypia2025
3Levonorgestrel-releasing intrauterine system treatment for endometrial hyperplasia and early endometrial cancer: a systematic reviewSystematic Review · 2026 · 1 citations
4Efficacy and safety of the levonorgestrel-releasing intrauterine system compared with oral progestogens for endometrial hyperplasia: a systematic review and meta-analysis of randomized controlled trialsMeta-Analysis · 2026
5109 GnRH agonist plus medroxyprogesterone acetate for fertility-sparing treatment of stage IA-G1 endometrial cancer and atypical endometrial hyperplasia2024